We show in this work the development of modified building blocks for the sy
nthesis of nuclease resistant hammerhead ribozymes. These modified monomers
retain the 2'-OH which is essential for the activity of these molecules. O
ur final goal is to generate a catalytic antisense approach with potential
application in gene therapy.